EUROKAI GmbH & Co. KGaA (HAM:EUK2)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	570	461	366	422	484	372
Market Cap Growth	25.72%	25.72%	-13.10%	-12.79%	30.04%	-17.47%
Enterprise Value	681	587	483	557	626	534
Last Close Price	41.40	33.54	26.15	29.08	30.62	24.34
PE Ratio	8.20	6.63	9.27	4.66	6.55	-
PS Ratio	2.26	1.83	1.67	1.70	2.07	1.89
PB Ratio	0.87	0.70	0.62	0.73	1.02	0.92
P/TBV Ratio	1.14	0.92	0.80	1.05	1.55	1.50
P/FCF Ratio	11.24	9.08	13.03	7.65	10.85	9.91
P/OCF Ratio	8.60	6.94	9.50	5.67	8.62	8.21
EV/Sales Ratio	2.70	2.33	2.21	2.25	2.68	2.71
EV/EBITDA Ratio	5.18	10.11	11.08	7.61	8.84	10.04
EV/EBIT Ratio	6.17	13.11	15.95	9.23	10.63	12.94
EV/FCF Ratio	13.42	11.56	17.19	10.10	14.05	14.23
Debt / Equity Ratio	0.32	0.32	0.37	0.39	0.52	0.62
Debt / EBITDA Ratio	3.19	3.19	4.14	2.85	3.13	4.12
Debt / FCF Ratio	4.14	4.14	7.73	4.13	5.45	6.62
Asset Turnover	0.27	0.27	0.24	0.29	0.31	0.25
Inventory Turnover	26.35	26.35	26.04	28.53	27.10	22.10
Quick Ratio	4.80	4.80	4.32	3.92	3.66	3.20
Current Ratio	4.98	4.98	4.53	4.12	3.80	3.67
Return on Equity (ROE)	14.07%	14.07%	8.88%	21.60%	21.72%	-6.97%
Return on Assets (ROA)	2.97%	2.97%	2.08%	4.41%	4.82%	3.29%
Return on Capital (ROIC)	3.33%	3.33%	2.34%	4.95%	5.39%	3.67%
Return on Capital Employed (ROCE)	5.10%	5.10%	3.60%	7.20%	8.10%	6.20%
Earnings Yield	12.19%	15.09%	10.79%	21.46%	15.26%	-12.07%
FCF Yield	8.90%	11.02%	7.68%	13.07%	9.21%	10.09%
Dividend Yield	4.46%	4.47%	4.97%	4.47%	3.27%	4.11%
Payout Ratio	46.55%	46.55%	52.05%	16.91%	21.46%	-
Buyback Yield / Dilution	-9.51%	-9.51%	-21.76%	-0.87%	-8.12%	19.45%
Total Shareholder Return	-5.04%	-5.04%	-16.79%	3.60%	-4.85%	23.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.